UroGen Pharma ^Investors

UroGen Pharma is a venture capital fund based in New York, New York, founded in 2004 The firm specializes in investing in innovative biopharmaceutical companies, particularly those focused on urology and oncology UroGen Pharma has a significant investment scale, with a total investment amounting to $58,149,000 The fund is committed to advancing therapeutic solutions that address unmet medical needs Through strategic partnerships and a robust portfolio, UroGen Pharma aims to enhance patient outcomes in the healthcare sector